Campaigning & Advocacy

As a charity we are actively involved in campaigning on behalf of patients and their carers, which we feel is an important part of the work that we do. We are passionate about doing everything we can to improve the experience of patients throughout their cancer journey.

Our campaigns

We run campaigns throughout the year, and need you to get involved and help raise awareness.

What is campaigning and advocacy?

As a charity we are actively involved in campaigning on behalf of patients and their carers, which we feel is an important part of the work that we do. We are passionate about doing everything we can to improve the experience of patients throughout their cancer journey.

Patient Advocacy Groups

We are involved with a number of organisations and coalitions on your behalf which, through collaborative working, aim to ensure that the collective voice of blood cancer patients is heard.

Working with the pharmaceutical industry

We work with the pharmaceutical industry to ensure that they take the interests of patients into account when developing new drugs and treatments for blood cancer patients.

Health Technology Appraisals

This involves working with bodies such as the National Institute for Health and Care Excellence (NICE), the Scottish Medicines Consortium (SMC) and the All Wales Medicines Strategy Group (AWMSG) to ensure that the views of patients are taken into account when making decisions over access to drugs and treatments.

About acute myeloid leukaemia (AML)

Acute myeloid leukaemia (AML) is a fast-growing blood cancer. It develops when myeloid stem cells in your bone marrow divide and mature uncontrollably. Find out about the signs and symptoms of AML, tests you might have, and what to expect.

Read More

Take a Moment to Catch Up

View our latest news and blog articles

November 25th

Obecabatagene autoleucel CAR-T approved by NICE: What you need to know

Today (Tuesday 25th November 2025) obecabtagene autoleucel (obe-cel) has been approved for use on NHS in most of the UK. It is a type of CAR-T cell therapy for certain adults with B cell acute lymphoblastic leukaemia (ALL). The brand name for obecel is Aucatzyl.  ...

November 23rd

Charity calls for more thoughtful giving as half of Brits admit to re-gifting

A new survey from Leukaemia Care has revealed the state of the nations gift giving...

November 22nd

Support available over Christmas

Find out what support is available for you over the 2025 Christmas period....